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osting by EAbstract Background: Traditional use of trans-annular patch (TAP) to release right ventricular
outﬂow tract (RVOT) obstruction during tetralogy of Fallot (TOF) repair may lead to a harmful
pulmonary regurgitation. Different approaches have been used to release RVOT obstruction and
spare the pulmonary valve (PV) function. In this study, we aim to evaluate the post-operative course
of patients who had TOF repair in the current era that emphasizes on protective strategy of releas-
ing RVOT obstruction and preserving PV function.
Methods: A retrospective study of all TOF cases repaired in our institute between March 2002
and December 2007 was conducted. Cases were classiﬁed into two groups; group I included patients
that had a TAP, while group II included cases that had simple TOF repair without TAP. Group I
was subdivided into two groups, group (A) which include patients who had TAP without a valve.
Group (B) includes those who had TAP with a monocuspid valve (Contegra). We compared post-
operative care and outcome of all groups.
Results: Eighty-three patients fulﬁlled the study criteria. There were 64 cases (77%) in group I,
and 19 cases (23%) in group II. All children tolerated surgical repair and did well. We observed noartment of Cardiac Sciences
ity, P.O. Box 22490, Riyadh
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56 S.R. Ismail et al.statistically signiﬁcant difference in the post-operative ICU care, complications rates and morbidity
between all groups. There was no surgical mortality in all groups.
Conclusion: Children undergoing TOF repair had excellent short-term outcome with the current
protective strategy aiming to spare valvular function, and conserving myocardial function. Apply-
ing a monocuspid patch technique did not show clear short-term beneﬁts. Long term follow up is
needed to evaluate future difference in different techniques.
ª 2010 King Saud University. All rights reserved.1. Introduction
Tetralogy of Fallot (TOF) is a spectrum of disease that ranges
from mild to severe form. In simple cases associated with mild
right ventricle outﬂow tract (RVOT) obstruction, surgical re-
pair of TOF can be accomplished without the need for patch
augmentation of the RVOT (Karl et al., 1992; Langc et al.,
1982; Stewart et al., 2005). In severe form of TOF, however,
there is a marked hypoplasia of the pulmonary annulus with
severe RVOT obstruction, then augmentation of the pulmon-
ary valve annulus using trans-annular patch (TAP) repair be-
comes inevitably necessary. TAP repair releases the
obstruction at the valvular, supra-valvular, and at the RVOT
levels but leads to pulmonary insufﬁciency that was once con-
sidered to be innocent, tolerated and not harmful.
With the long term follow up, however, studies have dem-
onstrated that many patient following TAP repair developed
severe pulmonary regurgitation (PR) with right ventricle dila-
tation and marked ventricular dysfunction (Murphy et al.,
1993; Nollert et al., 1997). Furthermore, dysfunctional right
ventricle in association with severe PR lead to poor functional
status, arrhythmia and in some instance sudden death (Karl
et al., 1992; Di Donato et al., 1991; Carvallho et al., 1992). Dif-
ferent to what was thought formerly to be well tolerated fol-
lowing TAP repair, signiﬁcant pulmonary regurgitation
turned out to be unsafe and harmful as it may progress to sig-
niﬁcant morbidity and even mortality (Kirklin et al., 1989;
Sunakawa et al., 1988; Cullen et al., 1995).
The current trend in the management strategy of TOF is to
preserve the pulmonary valve function as much as possible
with the aim to avoid future PR along with its deleterious con-
sequences (Stewart et al., 2005). Along that line, in our institu-
tion, various techniques have been used and applied to
preserve the pulmonary valvular function and prevent future
pulmonary regurgitation. These include avoidance of TAP
whenever possible, the use of limited TAP technique when
otherwise a patch is unavoidably needed with concomitant
acceptance of mild gradient at the RVOT, or the use of limited
patch tailored with monocuspid homograft (Contegra) valve
in the RVOT. The immediate adaptation of right ventricle to
the current conservative and protective surgical approaches
is an area of investigation and research. Furthermore, the
short and long term results of applying these various tech-
niques remain subject of debate, and follow up with analysis
(Bigras et al., 1996; Gundy et al., 1994).
In this study, we are aiming to explore the short-term ef-
fects and outcome of using our various techniques for TOF re-
pair that aim in essence to preserve the pulmonary valve and/
or its function in order to prevent right ventricle dilatation and
dysfunction. Our study is looking speciﬁcally to evaluate post-
operative ICU course following TOF repair and assessing thedifference in the short-term adaptation of patients to each and
different type of TOF repair.
2. Methods
We conducted a retrospective review of a prospectively col-
lected database of all cases of TOF repair that were done in
King Abdulaziz cardiac center between March 2002 and
December 2006. We excluded cases of TOF with pulmonary
atresia and cases of TOF with absent pulmonary valve. Sub-
jects were classiﬁed into two groups; group I included patients
that had a TAP, while group II included cases that had simple
TOF repair without TAP. Group I was subdivided into two
groups, group (A) which include patients who had TAP with-
out a valve. Group (B) includes those who had TAP with
monocuspid valve. The comparison was done ﬁrst between
the groups I and II, then between groups A and B. We com-
pared all groups in regards to their peri-operative data, and
short-term outcomes. These data include demographic infor-
mation, risk category, ICU parameters, ECHO (maximum
RVOT gradient pre and post surgery, post-operative develop-
ment of pulmonary regurgitation) and different morbidities
and early outcome of all groups.
2.1. Surgical technique
Intermittent cold cardioplegia was used. The approach used in
our cases is the trans-atrial and trans-pulmonary approach.
The ventricular septal defect closure was done through the tri-
cuspid valve. The decision to do TAP was dependant on the (Z
score) of the pulmonary annulus. If the Z score is >2 full
repair was done without the use of a TAP. If the Z score is
2 or smaller, a limited TAP was used for repair. The decision
to use the monocuspid TAP was based on the surgeon discre-
tion without any pre-determined objective criteria.
2.2. Statistical analysis
Preoperative and post-operative data on all patients were ex-
tracted from the medical records. Variables with a normal dis-
tribution are expressed as the mean ± standard deviation.
Differences were examined for signiﬁcance by univariate anal-
ysis (Student t test or chi-square test).
3. Results
Eighty-three patients fulﬁlled the study criteria. There were 64
cases (77%) in group I, and 19 (23%) cases in group II. Group
I was subdivided into two groups, group A had a limited TAP
without a valve and included 48 patients (75%), and group B
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patients (25%). All children had tolerated surgical repair very
well. When we ﬁrst compared groups I and II. There was no
statistically signiﬁcant difference in term of demographic data,
peri-operative data, and mortality (Table 1). We observed a
few differences in the incidence of post-operative complica-
tions; however, the difference did not reach statistical signiﬁ-
cance (Table 2). There was no surgical or hospital mortality
in any of the groups. There was one late-mortality in patient
from group (A), 3 months after discharge, due to respiratory
syncitial virus (RSV) bronchiolitis. In group (B) 16 patients
had a limited TAP with a monocuspid valve (Contegra),
immediately after surgery six of them had no evidence of any
pulmonary regurgitation while 10 patients had mild pulmon-
ary regurgitation. In group A 11 patients had moderate pul-
monary regurgitation and (37) developed sever pulmonary
regurgitation immediately post operatively (Table 3).4. Discussion
In our series, 23% of our patients were managed conserva-
tively with no patching. However in the rest of our patients
(77%), the pulmonary annulus was judged to be severely un-
der-developed prohibiting surgical repair without patch aug-
mentation. The reported need for TAP varies from center to
center. In a review of 160 patients underwent TOF repair,
the authors reported a need for TAP in 60% of their patients
(Kaushal et al., 1999). Others have reported lesser need for the
use of TAP and advocated preserving the pulmonary valve as
much as possible and accepting variable degree of residual
RVOT stenosis and RVOT gradient in trade of maintaining
PA annulas and valve integrity (Stewart et al., 2005; Morales
et al., 2009).
Although the larger portion of our patient had patch repair,
we were determined to limit the size of the patch used in our
cases to the minimum that would provide satisfactory RVOT
repair with acceptable RVOT residual gradient. As a result,
an RVOT gradient ranging between 12 ± 9 mm Hg in group
II and 16.5 ± 9 mm Hg group I was documented during the
post-operative period. The acceptable gradient in the post-
operative period is a subject of debate. A signiﬁcant gradient
associated with marked residual obstruction at the RVOT
may not be tolerated as it may lead to difﬁcult post-operative
course or need for re-intervention to release the remaining
obstruction. Multiple criteria have been used peri-operatively
to assess the adequacy of PA annuals and the ability to reach
satisfactory RVOT repair and size without need for patch aug-
mentation. These criteria may include; measuring the PATable 1 The comparison of the preoperative and operative data be
Variable Grou
Males/females 44/2
Average age (months) 18.8
Average weight (kg) 8.6 ±
Average of preoperative saturation 72.7
Average of bypass time (min) 104 ±
Average of preoperative RVOT max PG (mm Hg) 72.5
kg: Kilo-grams, max: maximum, PG: pressure gradient, mm Hg: millimeannuals Z score before surgery, scrutinizing the number of pul-
monary valve cusp, using Hegar’s dilator to properly size the
RVOT during surgery, measuring RVOT gradient by intra-
operative trans-esophageal echocardiography (TEE) and
assessing the right ventricle to left ventricle pressure ratio
(pRV/pLV) pre and post-repair. In general, residual RVOT
obstruction post-repair is considered signiﬁcant if RVOT gra-
dient exceeds 40 mm Hg or if pRV/pLV ratio exceeds 0.85
(Kaushal et al., 1999). In our series, we depended mainly on
the intra-operative TEE gradient measurement accepting max-
imum RVOT gradient of 40 mm Hg post-repair. None of our
patients had intra-operative RVOT gradient that exceeded
40 mm Hg post-repair and none required re-intervention dur-
ing their post-operative ICU course. Furthermore, the post-
operative course in our patients was generally well tolerated
with acceptable complications rate, freedom from invasive
mechanical support need, and there was no short-term mortal-
ity. The average ICU and hospital length of stay in our pa-
tients were approximately 5 and 11 days, respectively and all
cases were discharged home with satisfactory results.
There are, however, other investigators who follow slightly
different strategies but with same goal in essence. In recently
published study, the authors reported RVOT sparing repair
strategy in TOF patients that consists of a trans-atrial and
trans-pulmonary approach to close the ventricular septal de-
fect and resect RV infundibular muscle coupled with a mini
(<5 mm) trans-annular patch or no ventricular incision (Mor-
ales et al., 2009). Their short-term result is comparable to what
we have seen in our patient’s population, although long term
evaluation is still needed. Another study was also published re-
cently and reported the use of pulmonary valve sparing ap-
proach guided by intra-operative assessment of pRV/pLV
ratio. The authors noted during their follow up marked decline
in the pRV/pLV ratio by 16% in all patients after a median of
32.8 months of longitudinal follow up. The reduction in pRV/
pLV ratio was particularly noticeable (28%) in the sub-group
of patient who had the more conservative sparing approach
with pRV/pLV ratio >0.7 at the time of repair. The results
of the later study showed no early or late-mortality with only
one patient requiring late re-intervention due to residual steno-
sis. This highlighted the observation that RVOT gradient seen
immediately after repair tends to decrease with time as it was
observed frequently during late follow up of many patients
(Kaushal et al., 1999).
In severe cases of TOF repair that required PA augmenta-
tion, we adopted the use of limited TAP with or without
monocusp valve. Although we did not follow pre-determined
objective criteria for monocusp valve placement, it was gener-
ally reserved for the severe cases of pulmonary valve annulustween groups I and II.
p (1) Group (2) p value
0 12/7
± 24.4 SD 15.6 ± 16 SD 0.06
4.4 SD 6.9 ± 3.4 SD 0.12
± 6 SD 71 ± 5.3 SD 0.25
32 SD 86.8 ± 6.8 SD 0.04
± 19 SD 66 ± 18 SD 0.21
ter mercury.
Table 2 Comparison of the early post-operative data between groups I and II.
Variable Group (1) Group (2) p value
Pleural eﬀusion no. (%) (9) 14% (2) 10% 0.94
Arrhythmias no. (%) (14) 22% 12 atrial one ventricular (4) 21% two AVB two atrial 0.82
Pericardial eﬀusion no. (%) (6) 9% (1) 5% 0.93
Acute renal failure (with temporary dialysis) no. (%) (2) 3% 0% 0.92
New onset of seizure no. (%) (4) 6% (1) 5% 0.69
Chylothorax no. (%) (3) 5% 0%
Average inotropes duration (h) 62.35 ± 60.1 SD 41.8 ± 24 SD 0.18
Maximum no of inotropes 2 ± 0.5 SD 1.77 ± 0.7 SD 0.21
Average ventilation time (h) 46.4 ± 66 SD 26.1 ± 22.7 SD 0.22
Average ICU length of stay (days) 4.7 ± 3.6 SD 4.1 ± 1.8 SD 0.53
Average hospital length of stay (days) 10.8 ± 7.4 SD 8.1 ± 2.7 SD 0.19
Average of post-operative RVOT max PG (mm Hg) 16.5 ± 8.9 SD 12 ± 9 SD 0.14
No: Number, h: hours.
Table 3 Is comparing the group of patients with a limited TAP without a valve (A), with group (B) who had a monocuspid TAP
(Contegra).
Variable Group A Group B p value
Pleural eﬀusion no. (%) (8/48) 16.6% (1/16) 6.25% 0.29
Arrhythmias no. (%) (10) 20% (4) 25% 0.72
Pericardial eﬀusion no. (%) (6) 12.5% (0) 0% 0.13
Acute renal failure (with temporary dialysis) no. (%) (1) 2% (1) 6.25% 0.4
New onset of seizure no. (%) (4) 8.3% (0) 0% 0.23
Chylothorax no. (%) (3) 6.25% (0) 0% 0.3
Average inotropes duration (h) 64.6 ± 58.7 SD 50.2 ± 68.9 SD 0.43
Maximum no. of inotropes 2 ± 0.7 SD 1.9 ± 0.8 SD 0.63
Average ventilation time (h) 50.3 ± 67 SD 34.8 ± 72 SD 0.44
Average ICU length of stay (days) 4.8 ± 3.6 SD 4.5 ± 4.5 SD 0.74
Average hospital length of stay (days) 10.9 ± 7.4 SD 9.5 ± 7 SD 0.52
Average of post-operative RVOT max PG (mm Hg) 17 ± 9 SD 16.2 ± 7.9 SD 0.76
No: Number, h: hours, max: maximum, PG: pressure gradient, mm Hg: millimeter mercury.
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signiﬁcant future valve regurgitation after patching. Many
authors favor the use of a valved trans-annular patch that pro-
claim to decrease the degree of valve incompetency (Ikeda
et al., 1990; Bigras et al., 1996; Giannopoulos et al., 2004).
Various types and techniques have been reported in the litera-
ture to construct TAP with valve. These may include valved
homograft patch, biosynthetic monocuspid patch (Contegra),
a polytetraﬂuroethylene (PTFE) monocspid valve, and sepa-
rate trans-annular outﬂow patch (STOP) with turned-down
equine pericardial monocusp (Gundy et al., 1994; Turrentine
et al., 2002). We used the Contegra monocuspid valve in our
patients. When we compared our TOF patients who did not re-
quire (TAP), and those who required (TAP) with or without
monocusp, we observed no substantial difference in the ICU
course, outcome or complications rates between the two
groups (Table 3).
In spite of what appear to be good results seen immediately
after applying various type of valved TAP, the long term re-
sults are still in doubt. Studies have demonstrated limited
durability for those valves (Ikeda et al., 1990; Di Donato
et al., 1991; Alexioua et al., 2002). In one report, the authors
reported excellent short-term function but by within
24 months post-repair, only 14% of their patients with ahomograft monocusp TAP had a competent valve (Turrentine
et al., 2002). Similarly, in another report, it was noted that the
vast majority of the patients had deterioration of the (PTFE)
monocusp valve function within 3 years after repair. Propo-
nents of valved patch consider the remaining valvular function,
though regressed, and would still be a better and safer option
than the free PI experienced by the patients with the classic
valveless TAP (Alexioua et al., 2002). Many groups had aban-
doned the monocusp use as they appreciate no signiﬁcant
advantage for their patients (Bigras et al., 1996). In our series
we used the Contegra monocuspid TAP in twelve patients and
it signiﬁcantly decreased the incidence of post-operative PI,
but it failed to show any signiﬁcant improvement in the early
post-operative course in comparison with patient having the
classical limited TAP.5. Conclusion
In general, children undergoing TOF repair had good short-
term outcome with or without limited TAP. Adding a mono-
cuspid patch technique did not show any additional beneﬁt
over the classical limited TAP technique. The short-term out-
come of patients with TOF is excellent with valve sparing con-
Early outcome of tetralogy of Fallot repair in the current era of management 59servative repair. Patients tolerated well the procedure with
acceptable complications. Long term follow up is needed to as-
sess the fate of the conservative approach on cardiac morphol-
ogy and myocardial function.
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